| Cardiomyopathy and Myosin Studies | Lifetime | 62 | IT 6 | 99.48 |
| Viral Infections and Immunology Research | Lifetime | 74 | IT 4 | 99.26 |
| Cardiovascular Effects of Exercise | Lifetime | 70 | IT 6 | 99.46 |
| Cardiovascular Function and Risk Factors | Lifetime | 324 | IT 16 | 99.38 |
| Cardiac Structural Anomalies and Repair | Lifetime | 281 | IT 10 | 99.12 |
| Pericarditis and Cardiac Tamponade | Lifetime | 53 | IT 7 | 98.27 |
| Heart Failure Treatment and Management | Lifetime | 390 | IT 19 | 98.54 |
| Cardiac pacing and defibrillation studies | Lifetime | 431 | IT 20 | 98.71 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 168 | IT 11 | 97.75 |
| Eosinophilic Disorders and Syndromes | Lifetime | 611 | IT 55 | 95.84 |
| Potassium and Related Disorders | Lifetime | 897 | IT 42 | 85.83 |
| Takotsubo Cardiomyopathy and Associated Phenomena | Lifetime | 843 | IT 85 | 75.48 |
| Viral Infections and Immunology Research | 2021-2025 | 7 | IT 3 | 99.15 |
| Cardiomyopathy and Myosin Studies | 2021-2025 | 13 | IT 3 | 99.34 |
| Cardiovascular Effects of Exercise | 2021-2025 | 22 | IT 5 | 98.92 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 76 | IT 6 | 99.48 |
| Pericarditis and Cardiac Tamponade | 2021-2025 | 6 | IT 2 | 97.60 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 24 | IT 7 | 98.92 |
| Parathyroid Disorders and Treatments | 2021-2025 | 38 | IT 9 | 98.01 |
| Heart Failure Treatment and Management | 2021-2025 | 91 | IT 9 | 98.97 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 134 | IT 13 | 98.25 |
| Cardiac Structural Anomalies and Repair | 2021-2025 | 285 | IT 30 | 96.58 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 81 | IT 12 | 96.36 |
| Cardiac electrophysiology and arrhythmias | 2021-2025 | 565 | IT 55 | 93.08 |
| Medical Imaging and Pathology Studies | 2021-2025 | 266 | IT 18 | 87.39 |
| Acute Myocardial Infarction Research | 2021-2025 | 732 | IT 73 | 91.89 |
| Sarcoidosis and Beryllium Toxicity Research | 2021-2025 | 201 | IT 21 | 90.51 |
| Potassium and Related Disorders | 2021-2025 | 109 | IT 10 | 90.99 |
| Peptidase Inhibition and Analysis | 2021-2025 | 927 | IT 50 | 86.45 |
| Cardiac tumors and thrombi | 2021-2025 | 689 | IT 71 | 72.22 |
| GDF15 and Related Biomarkers | 2021-2025 | 576 | IT 17 | 54.92 |
| Takotsubo Cardiomyopathy and Associated Phenomena | 2021-2025 | 471 | IT 80 | 54.88 |
| Pneumothorax, Barotrauma, Emphysema | 2021-2025 | 403 | IT 59 | 38.22 |
| Cerebrovascular and genetic disorders | 2021-2025 | 919 | IT 40 | 24.79 |
| Genetics and Physical Performance | 2021-2025 | 887 | IT 29 | 18.72 |
